Volume 2 Issue 1
2018-09-17 Case Report
Abstract
Background: Invasive fungal infections cause significant morbidity and mortality in patients with hematologic malignancies and in recipients of hematopoietic stem cell transplantation.
Case: We report a patient with relapsed acute myeloid leukemia who developed disseminated Fusarium infection during the neutropenic period following the salvage cycle of chemotherapy given at King Fahad specialist Hospital in Dammam, Saudi Arabia. The invasive fungal infection was successfully managed with a combination of voriconazole and liposomal amphotericin-B.
Discussion: Fusarium species can cause invasive infections that may become disseminated and life-threatening in patients with acute myeloid leukemia.
Conclusion: Combined antifungal therapy and recovery of neutrophil count are essential to control invasive Fusarium infections.
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001007 Cite this Article
2018-01-19 Research Article
Summary
The effects of Leech Salivary Extract (LSE) on some haematological, immunological and organ weight parameters in rats, during a twenty eight days oral administration of 25, 50 and 100 mg/kg body weight doses, was investigated. LD50 and sub chronic toxicity was determined using standard methods. The oral LD50 was above 5000mg/kgbw. Oral administration of LSE (25mg/kgbw, 50mg/kgbw, 100mg/kgbw) for 28days had no significant (p>0.05) effect on the differential white blood cells (lymphocytes, monocytes, basophils, neutrophils, eosinophils), red blood cell indices (RBC count, PCV, HB, platelets, MCHC and MCH), feed intake, body weight gain and relative organ weight of lung, heart, liver, kidney, spleen and stomach of rats. However, the LSE evoked a significant (p>0.05) increase in the level of MCV in treated rats compared to the control. These results, indicating low toxicity and no negative significant effects of LSE on haemato-immunological indices in rats, suggest that the extract is safe for development and use as therapeutic for managing clinical conditions.
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001006 Cite this Article
2018-01-19 Research Article
Summary
Background and Aims: the Aim of the study was to find the level of protection among the healthcare workers (nurses, doctors, housekeeping staff and general duty assistants) by doing Anti-HBsAb titer and vaccinate those who were not properly immunized against HBV infection.
Materials and Methods: The study was approved by the Institutional review board of the Hospital. The study group included doctors, nurses, technical staff and lab attendants. Anti-HBs antibody titer was done on Vitros 3600 (OCD, USA). Tests were performed according to manufacturer’s instruction. Vaccine provided was Engerix B (GSK Glaxo, Belgium). Vaccination was provided to all employees had titer below 10 miu/ml.
Results: 489 of 794(61.5%) HCW had no history of previous vaccination and only 293 (36.9%) subjects had complete vaccination. Only 60.8 % (482/794) of the total subjects had titer above 10 miu/ml and were protected against Hepatitis B. Around 80.6% (246/305) of those who were fully vaccinated and 40.8% (237/489) of those who were not vaccinated previously had protective anti-HBs titers(>10 miu/ml). Majority (86.8%, 271/312) who had titer below 10 miu/ml were unvaccinated. Two of eight employees who had history of needle stick injury in past were found non-immune to Hepatitis-B infection.
Conclusion: Despite being involved in the procedures with high chances of infections through needle stick or other exposures, only one third of health care workers were vaccinated against hepatitis B. We recommend that all the HCWs should be vaccinated for Hepatitis B and their anti-HBs levels determined at regular intervals.
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001005 Cite this Article
Recent Articles
2021-02-10 Research Article
Gaurav Khichariya, Manjula K*, Subhashish Das and Kalyani R
2020-12-30 Opinion
Vyshnavi D*
2019-09-12 Case Report
Jose Osvaldo Barbosa Neto*, Joao Batista Santos Garcia, Thiago Alves Rodrigues and Camila Freitas de Andrade Rodrigues
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001013 Citation
2019-09-02 Review Article
Vincenzo Accurso*, Santoro M, Contrino AD, Casimiro P, Raso S, Carlisi M, Sardo M, Perez A, Di Piazza F, Russo A and Siragusa S
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001012 Citation
2019-08-08 Research Article
Muhammad Imran Qadir and Sani E Zahra*
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001011 Citation
2019-07-15 Research Article
Khalid Ahmed Al-Anazi*, Al-Anazi WK and Al-Jasser AM
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001010 Citation
2019-07-05 Editorial
Al-Anazi KA* and Al-Jasser AM
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001009 Citation
2019-05-03 Case Report
Al-Anazi KA*, Kanfar S, Aldayel A, Abduljalil O and Sayyed AH
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001008 Citation
2018-09-17 Case Report
AlShammasi S, AlNujaidi D, Bakhit K, Algarni A and AlAnazi KA*
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001007 Citation
2018-01-19 Research Article
Hausatu Babayi*, Ojo Olufunmilola Praise, Labake Fadipe Ajoke, Israel Kayode Olayemi, Elisha Baba and Oladosun Oluwale Peter
Abstract Read Full Article HTML DOI: 10.29328/journal.jhcr.1001006 Citation